3-DIFLUOROMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOLE
- $467 - $807
- Product name: 3-DIFLUOROMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOLE
- CAS: 938022-22-1
- MF: C8H10F2N2
- MW: 172.18
- EINECS:
- MDL Number:MFCD07779640
- Synonyms:3-DIFLUOROMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOLE
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
Package
- 100mg
- 250mg
- 1g
- 5g
- 10g
- ManufacturerChemenu
- Product numberCM234672
- Product description3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+%
- Packaging100mg
- Price$467
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM234672
- Product description3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+%
- Packaging1g
- Price$491
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM234672
- Product description3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+%
- Packaging250mg
- Price$576
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11008705
- Product description3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 97%
- Packaging5g
- Price$480
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11008705
- Product description3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 97%
- Packaging10g
- Price$807
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM234672 | 3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+% | 100mg | $467 | 2021-12-16 | Buy |
Chemenu | CM234672 | 3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+% | 1g | $491 | 2021-12-16 | Buy |
Chemenu | CM234672 | 3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 95+% | 250mg | $576 | 2021-12-16 | Buy |
Crysdot | CD11008705 | 3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 97% | 5g | $480 | 2021-12-16 | Buy |
Crysdot | CD11008705 | 3-(Difluoromethyl)-4,5,6,7-tetrahydro-1H-indazole 97% | 10g | $807 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|